Hakutulokset - Xing‐Juan Yu
- Näytetään 1 - 15 yhteensä 15 tuloksesta
-
1
GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma Tekijä Hong-Wei Sun, Xing-Juan Yu, Wenchao Wu, Jing Chen, Ming Shi, Limin Zheng, Jing Xu
Julkaistu 2016Artigo -
2
-
3
-
4
-
5
-
6
Increased Circulating Th17 Cells after Transarterial Chemoembolization Correlate with Improved Survival in Stage III Hepatocellular Carcinoma: A Prospective Study Tekijä Yuan Liao, Bo Wang, Zhi-Liang Huang, Ming Shi, Xing-Juan Yu, Limin Zheng, Shengping Li, Lian Li
Julkaistu 2013Artigo -
7
-
8
-
9
Expression patterns of programmed death ligand 1 correlate with different microenvironments and patient prognosis in hepatocellular carcinoma Tekijä Chaoqun Liu, Jing Xu, Zhongguo Zhou, Li-Lian Jin, Xing-Juan Yu, Gang Xiao, Jie Lin, Shi‐Mei Zhuang, Yaojun Zhang, Limin Zheng
Julkaistu 2018Artigo -
10
Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma Tekijä Bo Wang, Lian Li, Yuan Liao, Jinqing Li, Xing-Juan Yu, Yi Zhang, Jing Xu, Hui‐Lan Rao, Shupeng Chen, Lanjun Zhang, Limin Zheng
Julkaistu 2013Artigo -
11
-
12
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer Tekijä Jing Chen, Hong-Wei Sun, Yanyan Yang, Haitian Chen, Xing-Juan Yu, Wenchao Wu, Yi-Tuo Xu, Li-Lian Jin, Xiaojun Wu, Jing Xu, Limin Zheng
Julkaistu 2021Artigo -
13
WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition Tekijä Yun Zhou, Yongwen Huang, Xinping Cao, Jing Xu, Lan Zhang, Jianhua Wang, Long Huang, Shuting Huang, Linjing Yuan, Weihua Jia, Xing-Juan Yu, Rongzhen Luo, Min Zheng
Julkaistu 2016Artigo -
14
-
15
Työkalut:
Liittyvät aiheet
Medicine
Biology
Cancer research
Internal medicine
Hepatocellular carcinoma
Immunology
Pathology
Biochemistry
Cancer
Immune system
Immunohistochemistry
Oncology
Gene
Immunotherapy
Amino acid
CD68
CD8
Cancer immunotherapy
Carcinoma
Cell biology
China
Confidence interval
Downregulation and upregulation
Genetics
Glutamine
Hazard ratio
Myeloid
Nasopharyngeal carcinoma
Proportional hazards model
Radiation therapy